DUBLIN (AP) _ Prothena Corp. (PRTA) on Thursday reported a loss of $45.8 million in its third quarter.

On a per-share basis, the Dublin-based company said it had a loss of 97 cents.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.

The drug developer posted revenue of $1.5 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $26.7 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTA at https://www.zacks.com/ap/PRTA

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News